Lung Cancers Completed Phase 2 Trials for Thalidomide (DB01041)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00114192Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00053300Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00027638Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsTreatment
NCT00025285Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment